%0 Journal Article
%T Response to Drs Von Hoff and Renschler
%A Daniel H. Ahn
%A Tanios Bekaii-Saab
%J Archive of "Therapeutic Advances in Medical Oncology".
%D 2017
%R 10.1177/1758834017709238
%X Reply to Von Hoff and Renschler¡¯s Letter to the Editor re: Ahn et al. A modified regimen of biweekly gemcitabine and nab-paclitaxel in patients with metastatic pancreatic cancer is both tolerable and effective: a retrospective analysis. Ther Adv Med Oncolhttps://doi.org/10.1177/175883401667601
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5455884/